TRVI
Trevi Therapeutics, Inc. Common Stock
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$11.45
$-0.03
(-0.26%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $1.47B | EPS (ttm) | $-0.37 | Current Price | $11.45 |
| Enterprise Value | $1.27B | Forward EPS | $-0.44 | Previous Close | $11.48 |
| P/E Ratio | - | ROA | -23.93% | 52W High | $14.39 |
| Forward P/E | -25.77 | ROE | -36.87% | 52W Low | $3.77 |
| PEG Ratio | - | Gross Margin | - | 50 Day Avg | $11.93 |
| P/S Ratio | - | Operating Margin | - | 200 Day Avg | $8.88 |
| P/B Ratio | 7.74 | Profit Margin | - | Volume | 1.52M |
| EV/EBITDA | -24.89 | Current Ratio | 21.93 | Avg Volume | 1.84M |
| EV/Sales | - | Quick Ratio | 21.69 | Beta | 0.96 |
| Employees | 34.00 | Debt/Equity | 0.43 | Shares Outstanding | 128.23M |
| Sector | Healthcare | Total Debt | $823.00K | Float Shares | 95.23M |
| Industry | Biotechnology | Total Cash | $194.93M | Short Float | 13.95% |
| Optionable | Yes | Cash/Share | $1.52 | Short Ratio | 10.28 |
| Dividend Yield | - | Book Value/Share | $1.48 | % Held by Insiders | 0.68% |
| Target Price | $21.80 | Revenue (TTM) | - | % Held by Institutions | 105.54% |